IP Library › Assignment 061308/0844
Patent Assignment
Reel/Frame 061308/0844

Assignment of Assignor's Interest

Recorded: 2022-10-04 Pages: 6
Assignors
PIPKIN, JAMES D.
Executed: 2006-08-28
ZIMMERER, RUPERT O.
Executed: 2006-09-01
THOMPSON, DIANE O.
Executed: 2006-09-11
MOSHER, GEROLD L.
Executed: 2006-09-05
Assignee
CYDEX, INC.
10513 W. 84TH TERRACE, LENEXA, KANSAS, 66214
Covered Properties (4)
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
Patent: 9,827,324 →
Application: 13/586,380 →
Publication: US 2013/0059826
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
Application: 13/676,744 →
Publication: US 2013/0303498
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
Application: 15/817,056 →
Publication: US 2018/0154015
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
Application: 16/210,561 →
Publication: US 2019/0105404
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Oct 5, 2022
From: CYDEX, INC.
To: CYDEX PHARMACEUTICALS, INC.
Reel/Frame 061606/0837 →
Security Interest Oct 18, 2023
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; PFENEX INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065271/0025 →